Past Performers
|
Actelion Actelion focuses on the discovery, development, and commercialization of treatments for vascular endothelium diseases. (SWX: ATLN) |
|
Aviron Innovative vaccines. Acquired by MedImmune. |
|
Cellective Therapeutics Novel therapeutic antibodies for cancer and autoimmune diseases. Acquired by MedImmune. |
|
Collagen Products for the aesthetic, reconstructive, and obesity intervention markets. Acquired by Inamed. |
|
CoTherix Drugs for pulmonary diseases. Acquired by Actelion. |
|
CV Therapeutics Small-molecule drugs for the treatment of cardiovascular diseases. (NASDAQ: CVTX) |
|
Flamel Technologies Drug delivery system. (NASDAQ: FLML) |
|
InterMune Products for antibiotic-resistant infectious diseases. (NASDAQ: ITMN) |
|
Kosan Biosciences Novel polyketides for development as potential therapeutics. (NASDAQ: KOSN) |
|
Millennium Pharmaceuticals Therapeutic drug development. (NASDAQ: MLNM) |
|
Seattle Genetics Antibodies to treat cancer. (NASDAQ: SGEN) |
|
Threshold Pharmaceuticals Targeted cancer therapy. (NASDAQ: THLD) |